PURE Bioscience, Inc. (PURE)
OTCMKTS · Delayed Price · Currency is USD
0.0600
0.00 (0.00%)
Mar 10, 2026, 3:07 PM EST

Revenue by Segment

Millions USD. Fiscal year is Aug - Jul.
Fiscal Year
FY 2025FY 2024FY 2023FY 2022FY 2021FY 2020FY 2019FY 2018FY 2017FY 2016
Period Ending
Jul '25 Jul '24 Jul '23 Jul '22 Jul '21 Jul '20 Jul '19 Jul '18 Jul '17 Jul '16
Manufacture and Distribution of its Products
2.20M1.96M1.88M1.85M3.93M
Manufacture and Distribution of its Products Growth
12.18%4.58%1.30%-52.81%-43.23%
Total
2.20M1.96M1.88M1.85M3.93M
Total Growth
12.18%4.58%1.30%-52.81%-43.23%

Revenue by Geography

Millions USD. Fiscal year is Aug - Jul.
Fiscal Year
FY 2025FY 2024FY 2023FY 2022FY 2021FY 2020FY 2019FY 2018FY 2017FY 2016
Period Ending
Jul '25 Jul '24 Jul '23 Jul '22 Jul '21 Jul '20 Jul '19 Jul '18 Jul '17 Jul '16
United States
2.20M1.96M1.88M1.81M3.70M
United States Growth
12.18%4.58%3.53%-50.97%-45.45%
Total
2.20M1.96M1.88M1.81M3.70M
Total Growth
12.18%4.58%3.53%-50.97%-46.54%
Source: S&P Global Market Intelligence.